Ubs Group Ag Gsk PLC Put Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $1.93 Million - $2.29 Million	48,000 Added 2400.0%	50,000 $2.18 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $38,880 - $45,310	1,000 Added 100.0%	2,000 $88,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $2.44 Million - $2.71 Million	-62,800 Reduced 98.43%	1,000 $38,000
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $2.29 Million - $2.6 Million	62,800 Added 6280.0%	63,800 $2.54 Million
Q1 2021 May 12, 2021	BUY	$34.27 - $40.01 $13,708 - $16,004	400 Added 66.67%	1,000 $36,000
Q2 2017 Aug 14, 2017	BUY	N/A	200 Added 50.0%	600 $26,000
Q1 2017 Nov 14, 2017	BUY	N/A	400	400 $17,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.